Triazavirin—A Novel Effective Antiviral Drug

Triazavirin—A Novel Effective Antiviral Drug

This review outlines the data of numerous studies relating to the broad-spectrum antiviral drug Triazavirin that was launched on the Russian pharmaceutical market in 2014 as an anti-influenza drug (the international non-patented name is Riamilovir). The range of antiviral activity of Triazavirin has...

Full description

Bibliographic Details
Main Authors: Oleg N. Chupakhin, Vladimir L. Rusinov, Mikhail V. Varaksin, Evgeny N. Ulomskiy, Konstantin V. Savateev, Ilya I. Butorin, Weijie Du, Zhiyong Sun, Valery N. Charushin
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
triazavirin
riamilovir
SARS-CoV-2
COVID-19
antiviral therapy
Online Access:https://www.mdpi.com/1422-0067/23/23/14537

Internet

https://www.mdpi.com/1422-0067/23/23/14537

Similar Items